Preleukemia: the normal side of cancer

Area of Science:

• Hematology
• Oncology
• Stem Cell Biology

Background:

• Preleukemia represents an early stage in leukemia development.
• Hematopoietic stem/progenitor cells with specific mutations are implicated as the origin of various blood cancers.

Purpose of the Study:

• To define the preleukemic state.
• To enhance awareness and research into preleukemia.
• To facilitate targeted therapies for early-stage leukemia evolution.

Main Methods:

• Review of emerging evidence on preleukemic stem cells.
• Analysis of genetic mutations in hematopoietic stem/progenitor cells.
• Exploration of clonal expansion mechanisms.

Main Results:

• Preleukemic stem cells possess mutations conferring increased fitness and promoting clonal expansion.
• These cells can retain significant functionality.
• The preleukemic state is a precursor to both myeloid and lymphoid malignancies.

Conclusions:

• The preleukemic state is prevalent, affecting over 1% of individuals, and can persist for years without overt leukemia.
• Leukemia may arise not as a primary disease but as an adaptation of the hematopoietic system to aging.
• Preleukemic hematopoietic stem cells may initially function to maintain health, but acquired mutations can eventually lead to disease.